EGFR and cancer: One of the criteria of the selection of potential biomarkers was the differential expression not only between cancer and normal BEAS-2B cell lines, but also between A549 and HCC827 LC cells different in mutation status of the EGFR gene, one of the major pathological parameters in LC.